Stay updated on Atezolizumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Atezolizumab in Advanced NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding lapse notice was added to the page. The site revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary is now displayed; QC-related labels were updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Capitalization for 'No FEAR Act Data' has been standardized.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed as part of the site's versioning metadata on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now includes a Locations section listing Orlando, FL and Pittsburgh, PA, replacing the previous Florida Locations and Pennsylvania Locations blocks, and shows a new Revision: v3.3.3.SummaryDifference0.3%

Stay in the know with updates to Atezolizumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.